Conserved Domains and Related Protein Families
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
ID Alignment Graph Length
Definition
Probability
Query
96
COG0534 455
NorM Na+-driven multidrug efflux pump [Defense mec
98.4
PRK10189 478
MATE family multidrug exporter; Provisional
98.35
PRK10367 441
DNA-damage-inducible SOS response protein; Provisi
97.94
PRK01766 456
multidrug efflux protein; Reviewed
97.69
PRK00187 464
multidrug efflux protein NorA; Provisional
97.25
PRK09575 453
vmrA multidrug efflux pump VmrA; Reviewed
97.23
PF01554 162
MatE: MatE; InterPro: IPR002528 Characterised memb
97.21
PRK10189
478
MATE family multidrug exporter; Provisional
97.1
PRK10367
441
DNA-damage-inducible SOS response protein; Provisi
96.88
PRK00187
464
multidrug efflux protein NorA; Provisional
96.85
COG0534
455
NorM Na+-driven multidrug efflux pump [Defense mec
96.82
PRK09575
453
vmrA multidrug efflux pump VmrA; Reviewed
96.5
PRK01766
456
multidrug efflux protein; Reviewed
96.22
TIGR00797
342
matE putative efflux protein, MATE family. The MAT
95.55
TIGR02900 488
spore_V_B stage V sporulation protein B. SpoVB is
95.13
TIGR01695
502
mviN integral membrane protein MviN. This model re
93.34
KOG1347 473
consensus Uncharacterized membrane protein, predic
91.6
TIGR02900
488
spore_V_B stage V sporulation protein B. SpoVB is
91.13
TIGR00797 342
matE putative efflux protein, MATE family. The MAT
80.85
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Back Hide alignment and domain information
Probab=98.40 E-value=5.9e-07 Score=73.06 Aligned_cols=68 Identities=26% Similarity=0.344 Sum_probs=62.0
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
+|.|.++|+.+|+||++++|+.++..+. +++.+||..++.+
T Consensus 298 ~a~~~lvG~~~Ga~~~~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~ 377 (455)
T COG0534 298 QAVTILVGQNLGAGNYKRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQF 377 (455)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999988 8899999999999
Q ss_pred hhhhhhhcccchHHHHHHHHHHhhhcc
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRVDPAFG 69 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~a~~~g 69 (96)
+.+|.+.|+||.++....++.....++
T Consensus 378 v~~g~lrg~g~~~~~~~~~~~~~~~~~ 404 (455)
T COG0534 378 VLSGVLRGAGDAKIPFIISLLSYWGFR 404 (455)
T ss_pred HHHHHHHhcCCcHHHHHHHHHHHHHHH
Confidence 999999999999998888888754443
>PRK10189 MATE family multidrug exporter; Provisional
Back Show alignment and domain information
Probab=98.35 E-value=8.5e-07 Score=72.13 Aligned_cols=64 Identities=22% Similarity=0.205 Sum_probs=58.2
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
.|+|+++|+.+|++|++++|+..++.++ +++..||+.++.+
T Consensus 316 ~A~~~lvg~~~Ga~~~~~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~ 395 (478)
T PRK10189 316 SASTIITGTRLGKGQIAQAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASW 395 (478)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999987 7888899999999
Q ss_pred hhhhhhhcccchHHHHHHHHHHh
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~a 65 (96)
+++|++.|+||.++..+..+...
T Consensus 396 ~~~g~lrg~G~t~~~~~i~~~~~ 418 (478)
T PRK10189 396 VLPAGLKGARDARYAMWVSMLGM 418 (478)
T ss_pred HHHhHhhcCCCchHHHHHHHHHH
Confidence 99999999999999887766553
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Back Show alignment and domain information
Probab=97.94 E-value=2.7e-05 Score=62.71 Aligned_cols=63 Identities=16% Similarity=0.135 Sum_probs=48.4
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
.|.|+++|+.+|+||++++|+..++.++ +....+|++.+.+
T Consensus 289 ~a~~~lvg~~~Ga~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~ 368 (441)
T PRK10367 289 YAVEAHSGQAYGARDGSQLLDVWRAACRQSGIVALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCY 368 (441)
T ss_pred HHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999887 3334466666888
Q ss_pred hhhhhhhcccchHHHHHHHHHH
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRV 64 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~ 64 (96)
++|+++.|+.+....++.++.+
T Consensus 369 ~~~~~~~g~lrg~dt~~~~~~~ 390 (441)
T PRK10367 369 LLDGMFIGATRAAEMRNSMAVA 390 (441)
T ss_pred HHHHHhhCccchHHHHHHHHHH
Confidence 9999998888633333344443
>PRK01766 multidrug efflux protein; Reviewed
Back Show alignment and domain information
Probab=97.69 E-value=9.3e-05 Score=58.35 Aligned_cols=64 Identities=19% Similarity=0.098 Sum_probs=57.1
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
.|.++++|+++|+||++++|+..+..++ +....+|..++-+
T Consensus 296 ~a~~~~v~~~~Ga~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~ 375 (456)
T PRK01766 296 MALTIRVGFELGAGRTLDARQYAYIGLAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQV 375 (456)
T ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4788999999999999999999998887 6677788899999
Q ss_pred hhhhhhhcccchHHHHHHHHHHh
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~a 65 (96)
++.|++.|.||.++-.+..+...
T Consensus 376 ~~~~~l~g~g~~~~~~~~~~~~~ 398 (456)
T PRK01766 376 IGSGALRGYKDTRVIFFITFIAY 398 (456)
T ss_pred HHHhchhccCccHHHHHHHHHHH
Confidence 99999999999999888877754
>PRK00187 multidrug efflux protein NorA; Provisional
Back Show alignment and domain information
Probab=97.25 E-value=0.0008 Score=54.25 Aligned_cols=64 Identities=14% Similarity=0.026 Sum_probs=49.5
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH--------------------------------------------HHHhhccc
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ--------------------------------------------FVAGSQPM 37 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~--------------------------------------------~va~~QPi 37 (96)
.|.++++|+.+|+||++++++..++.+. +.+..+|.
T Consensus 293 ~a~~~lvgq~~Ga~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~ 372 (464)
T PRK00187 293 YAVTMRVGQHYGAGRLLEARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELF 372 (464)
T ss_pred HHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHh
Confidence 4789999999999999999999998877 12223444
Q ss_pred hhhhhhhhhhhhcccchHHHHHHHHHHh
Q 036574 38 NALAFVLDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 38 nglaFvlDGIl~GAgD~~YLA~a~l~~a 65 (96)
.++-+++.|++.|.||.++.....+...
T Consensus 373 ~~~~~v~~~~lrg~G~~~~~~~~~~~~~ 400 (464)
T PRK00187 373 DGTQTIAMGAIRGLKDARTTFLIGLACY 400 (464)
T ss_pred hHHHHHHHHhHhccCccHHHHHHHHHHH
Confidence 4455566789999999999777776654
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Back Show alignment and domain information
Probab=97.23 E-value=0.00088 Score=53.60 Aligned_cols=62 Identities=6% Similarity=0.094 Sum_probs=49.3
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH----------------------------------------HHHhhccchhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ----------------------------------------FVAGSQPMNALA 41 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~----------------------------------------~va~~QPingla 41 (96)
.+.|+++|+.+|+||++++|+..++.++ +.+..+|.-++-
T Consensus 292 ~a~~~lvg~~~Ga~~~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~ 371 (453)
T PRK09575 292 EGMQPPVSYYFGARQYDNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFL 371 (453)
T ss_pred HhhHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4789999999999999999999999998 455555666666
Q ss_pred hhhhhhhhcccchHHHHHHHHH
Q 036574 42 FVLDGLYYGVSDFEYAAYSMLR 63 (96)
Q Consensus 42 FvlDGIl~GAgD~~YLA~a~l~ 63 (96)
+++-+.+.|.||.++.-..++.
T Consensus 372 ~~~~~~~~~~g~~~~~~~~~~~ 393 (453)
T PRK09575 372 VLASAYFMAVNQGGKALFISIG 393 (453)
T ss_pred HHHHHHHHHcCCcHHHHHHHHH
Confidence 6666678999999886555443
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters
Back Show alignment and domain information
Probab=97.21 E-value=3.3e-05 Score=51.84 Aligned_cols=64 Identities=30% Similarity=0.396 Sum_probs=57.8
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
.+.|.++++..|++|+++++++.++.+. +.....|..++..
T Consensus 50 ~a~~~~~s~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (162)
T PF01554_consen 50 TALQILISQNIGAGDYKRAKKVVRQGLLLSLIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFF 129 (162)
T ss_dssp HHHHHHHCCCCCSSSTTTCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHH
T ss_pred ccccceeecccccccccccccccccccccchhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHH
Confidence 4679999999999999999999998888 7778899999999
Q ss_pred hhhhhhhcccchHHHHHHHHHHh
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~a 65 (96)
++.+++.|.||.++..+..+...
T Consensus 130 ~~~~~l~~~g~~~~~~~~~~~~~ 152 (162)
T PF01554_consen 130 VFSGILQGIGRTKIAMYISIISF 152 (162)
T ss_dssp HHCCCCGCCSTHCCCHHHHHHHH
T ss_pred HHHHHHHHCCcHHHHHHHHHHHH
Confidence 99999999999999888877765
These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
>PRK10189 MATE family multidrug exporter; Provisional
Back Show alignment and domain information
Probab=97.10 E-value=0.0016 Score=53.24 Aligned_cols=63 Identities=14% Similarity=0.119 Sum_probs=54.5
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH-----------------------------------------HHHhhccchhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ-----------------------------------------FVAGSQPMNAL 40 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~-----------------------------------------~va~~QPingl 40 (96)
.+.++++++.+|+||++++++..++.+. +....+|...+
T Consensus 86 ~g~~~lvsq~~Ga~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~ 165 (478)
T PRK10189 86 LGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAI 165 (478)
T ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHH
Confidence 4789999999999999999999888776 56677888999
Q ss_pred hhhhhhhhhcccchHHHHHHHHHH
Q 036574 41 AFVLDGLYYGVSDFEYAAYSMLRV 64 (96)
Q Consensus 41 aFvlDGIl~GAgD~~YLA~a~l~~ 64 (96)
.+++.+.+.|.||.+.-...++..
T Consensus 166 ~~~~~~~lr~~G~~~~~~~i~~~~ 189 (478)
T PRK10189 166 TLIGSGALRGAGNTKIPLLINGGM 189 (478)
T ss_pred HHHHHHHHHhcCchHHhHHHHHHH
Confidence 999999999999999877766554
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Back Show alignment and domain information
Probab=96.88 E-value=0.0032 Score=50.85 Aligned_cols=63 Identities=17% Similarity=0.121 Sum_probs=53.9
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
++.++++++.+|+||++++++..+..+. +.....|...+.+
T Consensus 67 ~g~~~lvsq~~Ga~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~ 146 (441)
T PRK10367 67 MSTTGLTAQAFGAKNPQALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANL 146 (441)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999888777 6677788889999
Q ss_pred hhhhhhhcccchHHHHHHHHHH
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRV 64 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~ 64 (96)
++.+++.|.||.+.--..+++.
T Consensus 147 ~~~~~lr~~G~~~~~~~~~ii~ 168 (441)
T PRK10367 147 VLLGWLLGVQYARAPVILLVVG 168 (441)
T ss_pred HHHHHHHHcccchHHHHHHHHH
Confidence 9999999999999866665554
>PRK00187 multidrug efflux protein NorA; Provisional
Back Show alignment and domain information
Probab=96.85 E-value=0.0033 Score=50.73 Aligned_cols=63 Identities=16% Similarity=0.049 Sum_probs=54.1
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH--------------------------------------HHHhhccchhhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ--------------------------------------FVAGSQPMNALAFV 43 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~--------------------------------------~va~~QPinglaFv 43 (96)
.+.++++++.+|++|++++|+..++.+. +.....|..++.++
T Consensus 67 ~~~~~i~aq~~Ga~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~ 146 (464)
T PRK00187 67 AAVGTLVAIRHGAGDIEGATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMA 146 (464)
T ss_pred HHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999888777 66677888899999
Q ss_pred hhhhhhcccchHHHHHHHHHH
Q 036574 44 LDGLYYGVSDFEYAAYSMLRV 64 (96)
Q Consensus 44 lDGIl~GAgD~~YLA~a~l~~ 64 (96)
+.+.+.|.||.+..-..+++.
T Consensus 147 ~~~~l~~~g~~~~~~~~~~~~ 167 (464)
T PRK00187 147 LRGFTSALGRAGPVMVISLAG 167 (464)
T ss_pred HHHHHHHcCCcHHHHHHHHHH
Confidence 999999999999866665544
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Back Show alignment and domain information
Probab=96.82 E-value=0.0031 Score=51.50 Aligned_cols=64 Identities=25% Similarity=0.394 Sum_probs=57.5
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
++..+++++++|+||++++|++.++.+. +.....|...+-+
T Consensus 74 ~g~~~liaq~~Ga~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~ 153 (455)
T COG0534 74 TGTTVLVAQAIGAGDRKKAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSF 153 (455)
T ss_pred HhHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999998887 7788889999999
Q ss_pred hhhhhhhcccchHHHHHHHHHHh
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~a 65 (96)
++.+.+.|.||.+.--+.++++.
T Consensus 154 ~~~~~lr~~G~~~~~m~~~~~~~ 176 (455)
T COG0534 154 VLSGILRGLGDTKTPMYILLLGN 176 (455)
T ss_pred HHHHHHHhcCCCchhHHHHHHHH
Confidence 99999999999999777777764
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Back Show alignment and domain information
Probab=96.50 E-value=0.0092 Score=47.83 Aligned_cols=63 Identities=17% Similarity=0.051 Sum_probs=51.1
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
.+.++++++.+|+||++++++..++.++ +.....|.-.+.+
T Consensus 70 ~g~~~lvsq~~Ga~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~ 149 (453)
T PRK09575 70 MGTGSLLSIKRGEGDLEKAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAI 149 (453)
T ss_pred ccHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999888 4555566777777
Q ss_pred hhhhhhhcccchHHHHHHHHHH
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRV 64 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~ 64 (96)
.+.+++.+.||.++....++..
T Consensus 150 ~~~~~l~~~g~~~~~~~~~~~~ 171 (453)
T PRK09575 150 ALPFLLRNDESPNLATGLMVIG 171 (453)
T ss_pred HHHHHHHcCCChHHHHHHHHHH
Confidence 8888899999988766665554
>PRK01766 multidrug efflux protein; Reviewed
Back Show alignment and domain information
Probab=96.22 E-value=0.015 Score=45.95 Aligned_cols=64 Identities=16% Similarity=-0.020 Sum_probs=52.3
Q ss_pred hhHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhh
Q 036574 2 SFSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAF 42 (96)
Q Consensus 2 IAgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaF 42 (96)
.+.+.++++++|++|++++++..++.++ +.....|..++.+
T Consensus 69 ~a~~~~vs~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~ 148 (456)
T PRK01766 69 LALTPIVAQLNGAGRRERIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQ 148 (456)
T ss_pred HHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999988877 3345567777778
Q ss_pred hhhhhhhcccchHHHHHHHHHHh
Q 036574 43 VLDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 43 vlDGIl~GAgD~~YLA~a~l~~a 65 (96)
++-+++.|.||.+...+.++...
T Consensus 149 ~~~~~l~~~g~~~~~~~~~~i~~ 171 (456)
T PRK01766 149 VLRSFIDGLGKTKPTMVIGFLGL 171 (456)
T ss_pred HHHHHHHHcCCChHHHHHHHHHH
Confidence 88889999999988777766553
>TIGR00797 matE putative efflux protein, MATE family
Back Show alignment and domain information
Probab=95.55 E-value=0.057 Score=40.20 Aligned_cols=63 Identities=27% Similarity=0.348 Sum_probs=52.0
Q ss_pred hHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhhh
Q 036574 3 FSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAFV 43 (96)
Q Consensus 3 AgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaFv 43 (96)
+.+..+++.+|++|++++++..++.++ +.....|..++..+
T Consensus 51 ~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~ 130 (342)
T TIGR00797 51 ATTALVAQAVGAGNYQRLGRQAQQSLLLALLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFV 130 (342)
T ss_pred hHHHHHHHHHCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 456678999999999999999888877 45556777777788
Q ss_pred hhhhhhcccchHHHHHHHHHHh
Q 036574 44 LDGLYYGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 44 lDGIl~GAgD~~YLA~a~l~~a 65 (96)
+.+++.|.+|+++..+..+...
T Consensus 131 ~~~~l~~~~~~~~~~~~~i~~~ 152 (342)
T TIGR00797 131 LRGFLRGQGDTKTPMYITLIGN 152 (342)
T ss_pred HHHHHHhcCCchHHHHHHHHHH
Confidence 8999999999999888877653
The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
>TIGR02900 spore_V_B stage V sporulation protein B
Back Show alignment and domain information
Probab=95.13 E-value=0.071 Score=41.77 Aligned_cols=62 Identities=15% Similarity=0.161 Sum_probs=50.2
Q ss_pred HHHHHHHhhcCCCHHHHHHHHHHHHH-----------------------------------HHHhhccchhhhhhhhhhh
Q 036574 4 SQALLAAGYSQGNYEQARQVVFRLLQ-----------------------------------FVAGSQPMNALAFVLDGLY 48 (96)
Q Consensus 4 gQALiG~aLGa~d~~~ar~v~~rvl~-----------------------------------~va~~QPinglaFvlDGIl 48 (96)
.+..+++..|++|.++.++..++..+ +.+..+|+.++..+..+++
T Consensus 295 ~~p~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l 374 (488)
T TIGR02900 295 LVPDISEAMAKKNYSSIEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRPDAGNFIRVLAPSFPFLYFSAPLQSIL 374 (488)
T ss_pred HHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34556899999999999999998887 5556677777777888899
Q ss_pred hcccchHHHHHHHHHHh
Q 036574 49 YGVSDFEYAAYSMLRVD 65 (96)
Q Consensus 49 ~GAgD~~YLA~a~l~~a 65 (96)
.+.||.++..+.++..+
T Consensus 375 ~~~g~~~~~~~~~~~~~ 391 (488)
T TIGR02900 375 QGLGKQKVALRNSLIGA 391 (488)
T ss_pred HhcCcchHHHHHHHHHH
Confidence 99999998888776664
SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
>TIGR01695 mviN integral membrane protein MviN
Back Show alignment and domain information
Probab=93.34 E-value=0.21 Score=39.41 Aligned_cols=26 Identities=19% Similarity=0.293 Sum_probs=22.4
Q ss_pred HHHHHHHhhcCCCHHHHHHHHHHHHH
Q 036574 4 SQALLAAGYSQGNYEQARQVVFRLLQ 29 (96)
Q Consensus 4 gQALiG~aLGa~d~~~ar~v~~rvl~ 29 (96)
.+..+++..|++|.+++|+..++.++
T Consensus 283 ~~P~~s~~~~~~~~~~~~~~~~~~~~ 308 (502)
T TIGR01695 283 LLPKLSRHASEGNWNELRDLLNQGIR 308 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHHHH
Confidence 45568999999999999999998887
This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Back Show alignment and domain information
Probab=91.60 E-value=0.062 Score=45.09 Aligned_cols=68 Identities=25% Similarity=0.148 Sum_probs=58.3
Q ss_pred hHHHHHHHhhcCCCHHHHHHHHHHHHH---------------------------------------HHHhhccchhhhhh
Q 036574 3 FSQALLAAGYSQGNYEQARQVVFRLLQ---------------------------------------FVAGSQPMNALAFV 43 (96)
Q Consensus 3 AgQALiG~aLGa~d~~~ar~v~~rvl~---------------------------------------~va~~QPinglaFv 43 (96)
|...-++..||+++++++|..+...+. +++.++.+|+.-.+
T Consensus 307 a~strv~neLGag~p~~ar~~~~v~~~~~~~~g~~~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v 386 (473)
T KOG1347|consen 307 AVSTRVSNELGAGKPKRARVSAKVALQTSVAIGASLGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAV 386 (473)
T ss_pred hHHHHHHHHHcCCChhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhh
Confidence 556678999999999999988877754 88899999999999
Q ss_pred hhhhhhcccchHHHHHHHHHHhhhccC
Q 036574 44 LDGLYYGVSDFEYAAYSMLRVDPAFGH 70 (96)
Q Consensus 44 lDGIl~GAgD~~YLA~a~l~~a~~~g~ 70 (96)
+.|+..|.|.-.+.|+..+....++|.
T Consensus 387 ~~Gva~g~g~q~~ga~vnl~~yyl~G~ 413 (473)
T KOG1347|consen 387 LSGVARGSGWQQIGAVINLVAYYLVGA 413 (473)
T ss_pred hhheEEeeccccceEEEeeeeeeEecC
Confidence 999999999999999988887655554
>TIGR02900 spore_V_B stage V sporulation protein B
Back Show alignment and domain information
Probab=91.13 E-value=0.72 Score=36.16 Aligned_cols=62 Identities=19% Similarity=0.319 Sum_probs=46.0
Q ss_pred hHHHHHHHhhcCCCHHHHHHHHHHHHH-----------------------------------HHHhhccchhhhhhhhhh
Q 036574 3 FSQALLAAGYSQGNYEQARQVVFRLLQ-----------------------------------FVAGSQPMNALAFVLDGL 47 (96)
Q Consensus 3 AgQALiG~aLGa~d~~~ar~v~~rvl~-----------------------------------~va~~QPinglaFvlDGI 47 (96)
+..-.+++..|++|++++++..+..+. +.....|+.++..++.+.
T Consensus 59 a~~~~is~~~~~~~~~~~~~~~~~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 138 (488)
T TIGR02900 59 AISKFVAEASAKNDRKNIKKILKVSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERSLYSLLVICPAMPFIALSSVLKGY 138 (488)
T ss_pred HHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 445567788999999999888776655 223445556667778999
Q ss_pred hhcccchHHHHHHHHHH
Q 036574 48 YYGVSDFEYAAYSMLRV 64 (96)
Q Consensus 48 l~GAgD~~YLA~a~l~~ 64 (96)
+.|-+|+++.+...+..
T Consensus 139 l~~~~~~~~~~~~~~i~ 155 (488)
T TIGR02900 139 FQGISNMKPPAYIQVIE 155 (488)
T ss_pred HhhhccchHhHHHHHHH
Confidence 99999999988776544
SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
>TIGR00797 matE putative efflux protein, MATE family
Back Show alignment and domain information
Probab=80.85 E-value=3.3 Score=30.76 Aligned_cols=42 Identities=12% Similarity=0.154 Sum_probs=31.6
Q ss_pred hHHHHHHHhhcCCCHHHHHHHHHHHHH-HHHhhccchhhhhhh
Q 036574 3 FSQALLAAGYSQGNYEQARQVVFRLLQ-FVAGSQPMNALAFVL 44 (96)
Q Consensus 3 AgQALiG~aLGa~d~~~ar~v~~rvl~-~va~~QPinglaFvl 44 (96)
+.+..+++.+|++|.++.|+..++.++ .+...-|+....+++
T Consensus 274 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 316 (342)
T TIGR00797 274 AVSILVGQALGAGDPKRAKEVARVALKLSLLLGLVLAIILILF 316 (342)
T ss_pred HHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 567788999999999999999998888 444455555544433
The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Homologous Structure Templates
Homologous Structure Domains